Ibogaine Derivative CKBR-12 For Parkinson’s

“Ibogaine’s mechanism of action influences the brain’s dopamine system, triggering neuroregeneration, an especially important factor in treating Parkinson’s patients. – Dr. Serge Przedborski, Columbia University”

At Genesis Ibogaine Institute, our ibogaine treatment center in Mexico, we are committed to exploring innovative solutions for Parkinson’s disease in collaboration with Ensenada Neuroplasticity Institute in Mexico, which we co-own. Parkinson’s disrupts the body’s natural rhythm, causing tremors, stiffness, and impaired coordination as dopamine-producing brain cells degenerate. With over 10 million people affected worldwide and no known cure, current conventional treatments only manage symptoms.
Ibogaine, a psychoactive alkaloid, shows great promise in regenerating dopamine-producing neurons by enhancing glial cell-derived neurotrophic factor (GDNF). This mechanism supports neurogenesis—the brain’s ability to form new neurons—helping slow disease progression. Unlike conventional yet invasive methods to boost GDNF, ibogaine offers a non-invasive alternative.
Its ability to stimulate GDNF production also makes ibogaine effective in reducing neuroinflammation as well as promoting neural repair mechanisms in other autoimmune/neurodegenerative conditions such as Multiple Sclerosis and Alzheimer’s disease.

Trials at Genesis Parkinson’s Institute have revealed ibogaine’s ability to significantly reduce motor symptoms like rigidity and tremors while improving quality of life. Case studies such as those conducted by Genesis Parkinson’s Institute have highlighted its significant impact on both motor and non-motor symptoms.
Together, we aim to advance ibogaine research and treatment, offering hope to those affected by Parkinson’s, Multiple Sclerosis and Alzheimer’s disease. Contact Tabula Rasa Retreat today to discover how ibogaine may bring healing and renewed quality of life to you or your loved ones..